Skip to Content

VG Life Sciences Inc

Rating as of

Company Profile

Business Description

VG Life Sciences Inc is a biotechnology company, which is engaged in developing transformative therapies to treat drug-resistant cancers, infectious diseases and autoimmune diseases caused by chronic inflammation. The company is focused on researching two technologies namely Targeted Peptide Technology which targets the body's immune cells and seems to explain the mechanism behind some autoimmune diseases while presenting a possible solution and Metabolic Disruption Technology which can be used in combination with a variety of existing drugs and compounds to treat drug-resistant cancers. Geographically activities of the group functioned through the region of United States.

121 Gray Avenue, Suite 200
Santa Barbara, CA, 93101
T +1 805 879-9000
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2015
Fiscal Year End Dec 31, 2015
Stock Type Distressed
Employees 1